Evidence map›Paper›PMID 40245354›Full record

ReviewAnnual review of biochemistry2025

Eukaryotic Microproteins.

Nadiya Jaunbocus, Valerie Ebenki, Haomiao Su, Sarah A Slavoff

Abstract readReview
In one paragraph

Review in Annual review of biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. bioRxiv : the preprint server for biology · 2026
    Article
  6. Microproteins: Uncovering Hidden Layers of the Proteome.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nadiya JaunbocusDepartment of Chemistry, Yale University, New Haven, Connecticut, USA; email: sarah.slavoff@yale.edu.
Valerie EbenkiDepartment of Chemistry, Yale University, New Haven, Connecticut, USA; email: sarah.slavoff@yale.edu.
Haomiao SuDepartment of Chemistry, Yale University, New Haven, Connecticut, USA; email: sarah.slavoff@yale.edu.
Sarah A SlavoffDepartment of Chemistry, Yale University, New Haven, Connecticut, USA; email: sarah.slavoff@yale.edu.

Funding

Translation of overprinted non-canonical open reading frames from alternative transcript variantsR01GM155404 · NIGMS · YALE UNIVERSITY · PI Sarah Ann Slavoff · 2024 to 2026
$1.3M
NIGMS NIH HHS R01 GM155404
6 · The paper itself

Abstract

Microproteins are polypeptides of 100-150 amino acids or fewer that have not been annotated by genome annotation consortia, given their small size and other noncanonical properties. Translated microproteins are now known to number in the thousands in the human genome, to function in critical cellular and physiological processes, and to be dysregulated or mutated in diseases including neurodegeneration and cancer. Knowledge about microproteins has rapidly accumulated since the advent of ribosome profiling enabled their global discovery 15 years ago. In this review, we summarize what is known about eukaryotic microprotein discovery, the sequences and expression mechanisms of small open reading frames, and microprotein functions from yeast to human.

Indexed as

PeptidesAnimalsHumansMicropeptidesOpen Reading FramesProtein BiosynthesisRibosomesSaccharomyces cerevisiaeMicropeptidesPeptidesmicroproteinsmall open reading framesmORF

Identifiers

PMID40245354
PMCPMC12207985

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.